[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2014004860A - Biomarcadores de cancer de pulmon y usos de los mismos. - Google Patents

Biomarcadores de cancer de pulmon y usos de los mismos.

Info

Publication number
MX2014004860A
MX2014004860A MX2014004860A MX2014004860A MX2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A
Authority
MX
Mexico
Prior art keywords
individual
cancer
lung cancer
biomarkers
methods
Prior art date
Application number
MX2014004860A
Other languages
English (en)
Other versions
MX355416B (es
Inventor
Stephen Alaric Williams
Michael Riel-Mehan
Edward N Brody
Alex A E Stewart
Rachel M Ostroff
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2014004860A publication Critical patent/MX2014004860A/es
Publication of MX355416B publication Critical patent/MX355416B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La presente solicitud incluye biomarcadores, métodos, dispositivos, reactivos, sistemas y kits para la detección y diagnóstico de cáncer de pulmón amicrocítico. En otro aspecto, la solicitud proporciona biomarcadores que pueden ser utilizados solos o en diversas combinaciones para diagnosticar cáncer de pulmón amicrocítico o cáncer general. En otro aspecto, se proporcionan métodos para diagnosticar cáncer de pulmón amicrocítico en un individuo, en donde los métodos incluyen detectar, en una muestra biológica de un individuo el valor de por lo menos un biomarcador que corresponde a un biomarcador que se selecciona del grupo de biomarcadores que se proporcionan en la Tabla 1, en donde al individuo se le clasifica que tiene cáncer de pulmón o se determina la probabilidad de que el individuo tenga cáncer de pulmón, en base en el valor de por lo menos un biomarcador. En otro aspecto, se proporcionan métodos para diagnosticar cáncer en un individuo, en donde los métodos incluyen detectar en una muestra biológica de un individuo por lo menos un valor de biomarcador que corresponde por lo menos un biomarcador que se selecciona del grupo de biomarcadores que se proporcionan en la Tabla 19, en donde al individuo se le clasifica que tiene cáncer o se le determina la probabilidad de que el individuo tenga cáncer en base en por lo menos un valor de biomarcador.
MX2014004860A 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos. MX355416B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
MX2014004860A true MX2014004860A (es) 2014-05-27
MX355416B MX355416B (es) 2018-04-18

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004860A MX355416B (es) 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos.

Country Status (15)

Country Link
EP (1) EP2771692B1 (es)
JP (1) JP5986638B2 (es)
KR (1) KR101921945B1 (es)
CN (2) CN106168624B (es)
AU (1) AU2011378427B8 (es)
BR (1) BR112014006432B8 (es)
CA (3) CA3064363C (es)
ES (1) ES2674318T3 (es)
IL (2) IL231426A (es)
IN (1) IN2014CN01787A (es)
MX (1) MX355416B (es)
NZ (1) NZ621733A (es)
SG (1) SG11201400375SA (es)
WO (1) WO2013062515A2 (es)
ZA (1) ZA201401476B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101870123B1 (ko) 2010-07-09 2018-06-25 소마로직, 인크. 폐암 바이오마커 및 그것의 용도
MX2015015452A (es) * 2013-05-09 2016-03-15 Procter & Gamble Metodo y sistema para evaluar una condicion de salud.
EP3175023A4 (en) 2014-07-30 2018-03-07 President and Fellows of Harvard College Systems and methods for determining nucleic acids
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
WO2017043679A1 (en) * 2015-09-11 2017-03-16 Aptamer Sciences Inc. Protein biomarker panel for detecting non-small cell lung cancer and method for diagnosing a non-small cell lung cancer by the use thereof
JP6688884B2 (ja) * 2015-11-05 2020-04-28 ビージーアイ シェンチェン 肺腺癌を検出するためのバイオマーカー及びその使用
CA3018066A1 (en) * 2016-03-18 2017-09-21 Caris Science, Inc. Oligonucleotide probes and uses thereof
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
EP3539036A4 (en) * 2016-11-08 2020-06-17 President and Fellows of Harvard College MATRIX AND DELETE
CN110402394B (zh) * 2017-03-01 2024-04-26 豪夫迈·罗氏有限公司 用于将关于分析物的存在的生物样品进行分类的系统和方法
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
CN113711313A (zh) * 2019-02-15 2021-11-26 佰欧迪塞克斯公司 用于识别手术后处于高复发风险的早期nsclc患者的预测性测试
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3316600A (en) * 1999-02-22 2000-09-21 Torben F. Orntoft Gene expression in bladder tumors
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
EP1787122B1 (en) * 2004-08-10 2010-10-06 Oncotherapy Science, Inc. NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTIONS WITH RhoA
JP2009502115A (ja) * 2005-07-27 2009-01-29 オンコセラピー・サイエンス株式会社 小細胞肺癌の診断方法
EP1937837A2 (en) * 2005-07-29 2008-07-02 Siemens Healthcare Diagnostics Inc. Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
US8445198B2 (en) * 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
ES2559758T3 (es) * 2008-09-09 2016-02-15 Somalogic, Inc. Biomarcadores de cáncer de pulmón y usos de los mismos
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN105039523A (zh) 2008-11-17 2015-11-11 威拉赛特公司 用于疾病诊断的分子表达谱的方法和组合物
US20110236903A1 (en) * 2008-12-04 2011-09-29 Mcclelland Michael Materials and methods for determining diagnosis and prognosis of prostate cancer
US9624547B2 (en) * 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer

Also Published As

Publication number Publication date
CA3006793A1 (en) 2013-05-02
IL252163A0 (en) 2017-07-31
JP5986638B2 (ja) 2016-09-06
EP2771692A4 (en) 2015-08-26
WO2013062515A2 (en) 2013-05-02
KR20140082840A (ko) 2014-07-02
CN103890586B (zh) 2016-06-29
CN106168624A (zh) 2016-11-30
ES2674318T3 (es) 2018-06-28
IL231426A0 (en) 2014-04-30
BR112014006432B1 (pt) 2021-04-06
CA3006793C (en) 2020-02-18
AU2011378427A1 (en) 2013-05-16
KR101921945B1 (ko) 2018-11-26
SG11201400375SA (en) 2014-04-28
BR112014006432B8 (pt) 2022-10-25
AU2011378427B8 (en) 2015-08-27
WO2013062515A3 (en) 2014-04-17
CA2847188C (en) 2020-02-18
NZ621733A (en) 2015-05-29
IL231426A (en) 2017-06-29
CA2847188A1 (en) 2013-05-02
EP2771692B1 (en) 2018-04-18
ZA201401476B (en) 2016-06-29
AU2011378427B2 (en) 2015-07-16
CN103890586A (zh) 2014-06-25
JP2015501154A (ja) 2015-01-15
IN2014CN01787A (es) 2015-05-29
EP2771692A2 (en) 2014-09-03
BR112014006432A2 (pt) 2017-04-04
AU2011378427A8 (en) 2015-08-27
CA3064363A1 (en) 2013-05-02
MX355416B (es) 2018-04-18
CN106168624B (zh) 2018-03-13
CA3064363C (en) 2022-05-17

Similar Documents

Publication Publication Date Title
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
GB2478441A (en) Lung cancer biomarkers and uses thereof
WO2014160275A3 (en) Biomarkers for liver fibrosis
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
EA030186B9 (ru) Способ проведения количественных анализов
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3135774A3 (en) Complex sets of mirnas as non-invasive biomarkers for kidney cancer
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
WO2013028807A3 (en) Renal cell carcinoma biomarkers and uses thereof
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012139052A3 (en) Antibody biomarkers for diabetes
GB201222576D0 (en) Method for diagnosing lung cancer
WO2014161910A3 (en) Methods and arrays for use in biomarker detection for prostate cancer
WO2012054824A3 (en) Prognostic biomarkers in patients with ovarian cancer
WO2012016216A3 (en) Assays for detection of glycosaminoglycans

Legal Events

Date Code Title Description
FG Grant or registration